HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

3-Iodobenzylguanidine

HCID 60860
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
80663-95-2
Standard SMILES
NC(N)=NCc1cccc(I)c1
InChIKey
PDWUPXJEEYOOTR-UHFFFAOYSA-N
Molecular formula
C8H10IN3
Average molar mass
275.09 g/mol
Monoisotopic mass
274.99194

Overview

2-[(3-iodophenyl)methyl]guanidine is an organoiodine compound.

Names & identifiers

Preferred name
3-Iodobenzylguanidine
IUPAC
2-[(3-iodophenyl)methyl]guanidine
English name
Caindexname:guanidine,[(3-iodophenyl)methyl]
Molecular formula
C8H10IN3
Molecular weight
275.09

Names & synonyms

3-Iodobenzylguanidinem Iodobenzylguanidine3 Iodobenzylguanidinemeta IodobenzylguanidineRefChem:94458123I Labeled 3-Iodobenzylguanidine125I Labeled 3-Iodobenzylguanidine3 Iodobenzylguanidine, 123I Labeled3 Iodobenzylguanidine, 125I LabeledIobenguane80663-95-21-(3-Iodobenzyl)guanidine
Show more names
Iobenguane sulfateM-iodobenzylguanidine hemisulfateIobenguane-d413C,15N2]-IobenguaneN-[(3-iodophenyl)methyl]GuanidineGuanidine, N-[(3-iodophenyl)methyl]-m-Iodobenzoylguanidine Hemisulfate SaltCaindexname:guanidine,[(3-iodophenyl)methyl]m-Iodobenzylguanidine hemisulphate salt, ≥98%
m-IodobenzylguanidineMetaiodobenzylguanidine2-[(3-iodophenyl)methyl]guanidineGuanidine,N-[(3-iodophenyl)methyl]-MIBGmeta-IodobenzylguanidineMFCD00133520Iobenguane (127-i)

Database identifiers

CAS
80663-95-2
PubChem CID
60860
DTXSID
DTXSID4048438
ChEMBL
CHEMBL818
ChEBI
CHEBI:92769
UNII
35MRW7B4AD
EC Number
688-301-9
Nikkaji
J360.168D

Properties

Computed structural properties

XLogP
1
Topological polar surface area
64.4 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
1
Rotatable bonds
2
Heavy atoms
12
Formal charge
0
Complexity
166

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
SolubilitySoluble
Human DrugsBreast Feeding; Lactation; Milk, Human; Radiopharmaceuticals; Iodine Radioisotopes; Diagnostic Agents
Boiling Point100°C
Melting Point0°C

Physicochemical properties

Boiling point
351.3 · 351.3±52.0 °C(Predicted)
Density
1.85 · 1.85±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C
pka
12.43 · 12.43±0.70(Predicted)
Appearance
White to off-white Solid
CAS DataBase Reference
80663 · 80663-95-2
FDA UNII
35 MRW7B4AD · 35MRW7B4AD
Symbol(GHS)
7 · GHS07

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS ClassificationNot Classified

Hazard information

Hazard Classes and CategoriesNot Classified

Toxicology

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Safety data

wgk
3
hs_code
29252900
Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P280-P305+P351+P338

Chemistry & industry

Pharmacology

Pharmacodynamics · 1 item

AdreView is a diagnostic radiopharmaceutical which contains a small quantity of iobenguane that is not expected to produce a pharmacodynamic effect. Patients with renal insufficiency may experience increased radiation exposure and impaired imaging results.

Mechanism of Action · 1 item

Structure of iobenguane is similar to noradrenaline so it can be taken up by adrenergic tissue in the adrenal medulla, liver, heart, and spleen. Once taken up by noradrenaline transporters in the adrenergic nerve terminals, it is stored in the presynaptic storage vesicles. The radioactive iodine component is responsible for its imaging properties.

Biological Half-LifePhysical half life = 13.2 hours
Metabolism/MetabolitesLess than 10% of the dose is metabolized into m-iodohippuric acid (MIHA). However the mechanism in which this metabolite is produced is unknown.
MeSH Pharmacological Classification · 3 items

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)

Absorption, Distribution and Excretion · 2 items

Iobenguane rapidly clears from the blood and is highly retained in adrenergic tissues.

Renally excreted unchanged (70%-90%) via glomerular filtration; Fecal (<1%)

Applications

Usesm-Iodobenzylguanidine Hemisulfatecan be used to demethylate and oxidize membrane-associated DNA. It has also been employed to develop a cell-based high-throughput screening assay to identify anti-hepatitis C virus compounds.

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
280 · P280-P305+P351+P338
WGK Germany
3 · 3
HS Code
29252900 · 29252900

Additional notes

DefinitionChEBI: 2-[(3-iodophenyl)methyl]guanidine is an organoiodine compound.